維生素 D 檢測市場 - 全球產業規模、佔有率、趨勢、機會及預測，按產品、適應症、最終用戶、地區及競爭細分，2020-2030 年預測

2024年，全球維生素D檢測市場規模達10.1億美元，預計2030年將達16.5億美元，複合年成長率為8.48%。全球維生素D檢測市場正持續成長，這得益於人們對維生素D缺乏症認知的提高、診斷技術的進步以及對預防性醫療保健的日益重視。隨著醫療保健提供者、政府機構和消費者逐漸認知到維生素D在整體健康和疾病預防中的重要作用，市場規模持續擴張。

受不斷上升的缺陷率、尖端檢測方法的創新、積極的醫療保健舉措以及不斷成長的醫療支出的推動，該行業有望持續發展。隨著診斷解決方案可近性的提高，預計市場將持續成長，技術也將持續革新，從而鞏固其在全球健康管理中的地位。

關鍵市場促進因素

維生素D缺乏症盛行率上升

主要市場挑戰

測試成本高且可訪問性有限

主要市場趨勢

更加重視預防性醫療保健

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：維生素D檢測市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品（25-羥基維生素 D 測試、1,25-二羥基維生素 D 測試）
  • 依適應症（骨質疏鬆症、佝僂病、甲狀腺疾病、維生素 D 缺乏症等）
  • 按最終使用者（醫院、診斷實驗室、家庭護理、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美維生素 D 檢測市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲維生素D檢測市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太維生素 D 檢測市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美維生素D檢測市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲維生素 D 檢測市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 併購

第 13 章：全球維生素 D 測試市場：SWOT 分析

第 14 章：競爭格局

• Abbott Laboratories Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Quest Diagnostics Incorporated
• bioMerieux
• DiaSorin SpA
• Thermo Fisher Scientific Inc
• Beckman Coulter, Inc.
• Tosoh Bioscience, Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

Global Vitamin D Testing market was valued at USD 1.01 Billion in 2024 and is expected to reach USD 1.65 Billion by 2030 with a CAGR of 8.48%. The Global Vitamin D Testing market is experiencing consistent growth, fueled by heightened awareness of vitamin D deficiency, advancements in diagnostic technologies, and the increasing emphasis on preventive healthcare. As healthcare providers, government agencies, and consumers acknowledge the essential role of vitamin D in overall well-being and disease prevention, the market continues to expand.

The industry is positioned for sustained development, driven by rising deficiency rates, cutting-edge innovations in testing methods, proactive healthcare initiatives, and growing healthcare expenditures. As accessibility to diagnostic solutions improves, the market is expected to experience continuous growth and technological evolution, reinforcing its role in global health management.

Key Market Drivers

Rising Prevalence of Vitamin D Deficiency

The increasing prevalence of vitamin D deficiency has become a major global health concern, significantly driving the demand for vitamin D testing solutions. Vitamin D deficiency is a widespread global health issue, with research indicating high prevalence rates across multiple regions. In India, studies estimate that 50% to 99% of the population may be affected. As awareness grows regarding the critical role of vitamin D in maintaining overall health, healthcare providers, governments, and diagnostic companies are focusing on early detection and intervention, fueling market expansion. Vitamin D deficiency is widespread, affecting populations across various age groups and geographic regions. Epidemiological studies indicate that vitamin D deficiency is highly prevalent among children, with reported rates ranging from 50% to 94%. This widespread deficiency is primarily attributed to insufficient sunlight exposure, inadequate dietary intake, and cultural practices that limit access to vitamin D-rich foods or outdoor activities. Aging populations, as older adults experience reduced vitamin D synthesis in the skin. Medical conditions such as obesity, kidney disease, and malabsorption disorders, which impair vitamin D metabolism.

Governments and healthcare organizations worldwide are implementing public health campaigns to educate individuals about the risks associated with vitamin D deficiency. These initiatives emphasize routine screening, particularly for high-risk groups, including Elderly individuals, who are more susceptible to osteoporosis and fractures. Pregnant women, as vitamin D is essential for fetal development. Patients with chronic illnesses, such as cardiovascular diseases and autoimmune disorders. The integration of vitamin D testing into preventive healthcare programs has led to higher adoption rates, further driving market growth. Scientific research has established a strong correlation between vitamin D deficiency and various chronic conditions, including Osteoporosis & Bone Disorders - Vitamin D is crucial for calcium absorption, and deficiency increases the risk of fractures and bone loss. Studies suggest that low vitamin D levels may contribute to hypertension and heart disease. Deficiency is linked to increased susceptibility to infections and autoimmune disorders. As healthcare providers recognize the importance of vitamin D testing in disease prevention and management, demand for accurate diagnostic solutions continues to rise.

The growing need for efficient and precise vitamin D testing has led to significant advancements in diagnostic technologies. Innovations such as: Chemiluminescence immunoassays (CLIA) for high-sensitivity detection. Liquid chromatography-mass spectrometry (LC-MS) for accurate measurement of vitamin D metabolites. Home-based test kits, enabling individuals to monitor their vitamin D levels conveniently. These advancements have enhanced accessibility, making vitamin D testing more cost-effective and widely available, further accelerating market growth.

Key Market Challenges

High Cost of Testing & Limited Accessibility

Expensive diagnostic procedures remain a significant barrier, particularly in developing regions where healthcare infrastructure is less advanced. Many vitamin D tests, especially 25-hydroxy vitamin D assays, require specialized equipment and trained professionals, increasing operational costs for laboratories and healthcare providers.

The lack of reimbursement policies for routine vitamin D testing in certain countries discourages patients from undergoing regular screenings, limiting market penetration. In rural and underserved areas, access to advanced diagnostic facilities is restricted, preventing widespread adoption of vitamin D testing.

Key Market Trends

Increasing Focus on Preventive Healthcare

The global healthcare landscape is shifting toward preventive care, with a growing emphasis on early diagnosis and proactive management of health conditions. Vitamin D plays a critical role in maintaining bone health, immune function, and cardiovascular stability, making routine testing an essential part of preventive healthcare strategies. Vitamin D deficiency is associated with an array of chronic conditions, including osteoporosis, cardiovascular diseases, autoimmune disorders, and metabolic syndromes. As awareness of these risks increases, healthcare providers and organizations are advocating for regular vitamin D screening, particularly among high-risk populations such as the elderly, individuals with limited sun exposure, and those with underlying health conditions.

Governments and healthcare institutions are implementing public health initiatives that emphasize early detection and intervention to reduce the burden of vitamin D-related diseases. Routine screening is now being integrated into wellness programs, corporate healthcare offerings, and primary care check-ups. Medical professionals are recommending vitamin D testing for patients experiencing fatigue, joint pain, depression, and muscle weakness, which are often linked to deficiencies. Additionally, the rising consumer-driven approach to health and wellness has fueled demand for personalized nutrition plans, where vitamin D assessment plays a significant role. Many individuals are proactively seeking testing services to optimize their vitamin D intake through supplementation, dietary adjustments, and lifestyle modifications. The expanding availability of direct-to-consumer testing kits allows people to monitor their vitamin D levels conveniently, further reinforcing this trend.

Key Market Players

• Abbott Laboratories Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Quest Diagnostics Incorporated
• bioMerieux
• DiaSorin S.p.A.
• Thermo Fisher Scientific Inc
• Beckman Coulter, Inc.
• Tosoh Bioscience, Inc

Report Scope:

In this report, the Global Vitamin D Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin D Testing Market, By Product:

• 25-Hydroxy Vitamin D Test
• 1,25-Dihydroxy Vitamin D Test

Vitamin D Testing Market, By Indication:

• Osteoporosis
• Rickets
• Thyroid Disorders
• Vitamin D Deficiency
• Others

Vitamin D Testing Market, By End User:

• Hospitals
• Diagnostic Laboratories
• Homecare
• Others

Vitamin D Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin D Testing Market.

Available Customizations:

Global Vitamin D Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Vitamin D Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (25-Hydroxy Vitamin D Test, 1,25-Dihydroxy Vitamin D Test)
  • 5.2.2. By Indication (Osteoporosis, Rickets, Thyroid Disorders, Vitamin D Deficiency, Others)
  • 5.2.3. By End User (Hospitals, Diagnostic Laboratories, Homecare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Vitamin D Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vitamin D Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Vitamin D Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Vitamin D Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By End User

7. Europe Vitamin D Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Vitamin D Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Vitamin D Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Vitamin D Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By End User
  • 7.3.4. France Vitamin D Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Vitamin D Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By End User

8. Asia-Pacific Vitamin D Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Vitamin D Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By End User
  • 8.3.2. India Vitamin D Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Vitamin D Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Vitamin D Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Vitamin D Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By End User

9. South America Vitamin D Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Vitamin D Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Vitamin D Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Vitamin D Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By End User

10. Middle East and Africa Vitamin D Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Vitamin D Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Vitamin D Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Vitamin D Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Vitamin D Testing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Danaher Corporation
• 14.3. F. Hoffmann-La Roche Ltd
• 14.4. Siemens Healthineers AG
• 14.5. Quest Diagnostics Incorporated
• 14.6. bioMerieux
• 14.7. DiaSorin S.p.A.
• 14.8. Thermo Fisher Scientific Inc
• 14.9. Beckman Coulter, Inc.
• 14.10.Tosoh Bioscience, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer